Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Psilocybin assisted therapy
COMBINATION_PRODUCT
2 trials
Sponsors
King's College London
, University of New Mexico
Conditions
Suicidal Ideation
Treatment Resistant Depression
Phase 2
Psilocybin in Depression Resistant to Standard Treatments
NCT04959253
King's College London
Treatment Resistant Depression
Start: 2020-09-01
End: 2023-11-01
Target: 60
Updated: 2021-07-22
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Withdrawn
NCT07484906
University of New Mexico
Suicidal Ideation
Start: 2026-05-01
End: 2029-08-31
Updated: 2026-03-20
Related Papers
Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial
BMJ Open
2021-12-01
19 citations